Citation Impact
Citing Papers
A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
2002 Standout
Prospective Study of Obstructive Sleep Apnea and Incident Coronary Heart Disease and Heart Failure
2010 Standout
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The autonomic tone and reflexes after myocardial infarction substudy)
2002
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Heart-Rate Profile during Exercise as a Predictor of Sudden Death
2005 Standout
Prevalence of Left Atrial Thrombus and Dense Spontaneous Echo Contrast in Patients With Short-Term Atrial Fibrillation < 48 Hours Undergoing Cardioversion: Value of Transesophageal Echocardiography to Guide Cardioversion
2009
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Prevention of Implantable-Defibrillator Shocks by Treatment with Sotalol
1999
Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone
2000
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations
2003
Consecutive screening and enrollment in clinical trials: The way to representative patient samples?
1998
Clinical trials of arrhythmia management: Methods or madness
1996
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
1997 Standout
The Quality of Health Care Delivered to Adults in the United States
2003 Standout
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
1999
Wound repair and regeneration
2008 StandoutNature
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials
2003
Acetylcholine from vagal stimulation protects cardiomyocytes against ischemia and hypoxia involving additive non‐hypoxic induction of HIF‐1α
2005
Exercise Standards for Testing and Training
2013 Standout
Cause of death in clinical research
1999
Adenosine for wide-complex tachycardia: Efficacy and safety*
2009
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation
2011
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation
2002
Causes of Death for Patients With Community-Acquired Pneumonia
2002
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
Prognosis determination in heart failure
2001
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
2002 Standout
The MUSTT Study: Evaluating Testing and Treatment
2000
Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy
2003
Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required?
1998
Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials
2009
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
1999 Standout
Value of non-invasive and invasive studies in patients with bundle branch block, syncope and history of myocardial infarction
2001
Sudden Cardiac Death: Exploring the Limits of Our Knowledge
2001
Antiarrhythmic Therapies for the Prevention of Sudden Cardiac Death
1997
Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias
1999
Myocarditis
2011 Standout
Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction
1996
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance
2009
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
2002 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Task Force on Sudden Cardiac Death of the European Society of Cardiology
2001
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention
2011
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
1997 Standout
Myocarditis
2000 Standout
Adjunctive Drug Therapy of Acute Myocardial Infarction — Evidence from Clinical Trials
1996
Sudden Death Due to Cardiac Arrhythmias
2001
Value of Programmed Ventricular Stimulation in Patients with Congenital Heart Disease
1999
Predictors of appropriate implantable cardioverter-defibrillator therapy in patients with idiopathic dilated cardiomyopathy
2002
Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues
2003
Predicting Mortality Among Patients Hospitalized for Heart Failure
2003 Standout
Regulation of cardiac hypertrophy by intracellular signalling pathways
2006 Standout
Carvedilol's antiarrhythmic properties: Therapeutic implications in patients with left ventricular dysfunction
2005
Sympathetic activation, ventricular repolarization and Ikrblockade: Implications for the antifibrillatory efficacy of potassium channel blocking agents
1995
Gender differences in arrhythmias
2002
Protective Effect of Amiodarone but Not N-Desethylamiodarone on Postischemic Hearts through the Inhibition of Mitochondrial Permeability Transition
2003
Intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment?
2007
Transcatheter closure of patent foramen ovale in older adults
2006
Mortality in the Survival With ORal D-Sotalol (SWORD) Trial: Why Did Patients Die? 11This work was supported by a grant from Bristol-Myers Squibb, Princeton, New Jersey.
1998
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
2005 Standout
Increased Mortality after Dronedarone Therapy for Severe Heart Failure
2008
Myocarditis
2009 Standout
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Atrial Therapies Reduce Atrial Arrhythmia Burden in Defibrillator Patients
2001
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Canadian Implantable Defibrillator Study (CIDS)
2000
A Decade of Clinical Trial Developments in Postmyocardial Infarction, Congestive Heart Failure, and Sustained Ventricular Tachyarrhythmia Patients: From CAST to AVID and Beyond
1998
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
1997 Standout
Characterization of Different Subsets of Atrial Fibrillation in General Practice in France
1999
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Amiodarone Interaction With β-Blockers
1999
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Part 9: Post–Cardiac Arrest Care
2010 Standout
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
2011 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Long-Term Comparison of the Implantable Cardioverter Defibrillator Versus Amiodarone
2004
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Sudden Cardiac Death
1998 Standout
Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device
2009 Standout
Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation
2005
Design and Results of the Antiarrhythmics vs Implantable Defibrillators (AVID) Registry
1999
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Nitrendipine
1987
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
2006
Multicenter Automatic Defibrillator Implantation Trial II (MADIT II): Design and Clinical Protocol
1999
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches
1999
Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter
2000
Asymptomatic or “Silent” Atrial Fibrillation
2003
Part 8: Adult Advanced Cardiovascular Life Support
2010 Standout
Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation
2000
Works of AJ Camm being referenced
Survival with oral d-Sotalol in patients with left ventricular dysfunction after myocardial infarction: Rationale, design, and methods (the SWORD trial)
1995
Ventricular tachycardia as default diagnosis in broad complex tachycardia
1994
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT
1997
Evaluating the place of low-molecular-weight heparin in the management of acute coronary syndromes
2001
Age and Gender Influences on Rate and Duration of Paroxysmal Atrial Fibrillation
1998
Clinical Relevance of Silent Atrial Fibrillation: Prevalence, Prognosis, Quality of Life, and Management
2000
The effects of oral nitrendipine and propranolol, alone and in combination, on hypertensive patients with special reference to AV conduction.
1986